|(S)-2-(4-(哌啶-3-基)苯基)-2H-吲哚-7-羧酸|CsnPharm

CAS No.: 1476777-06-6

Niraparib metabolite M1/尼拉帕尼代谢物 Catalog No. CSN19131

Synonyms: Niraparib carboxylic acid metabolite M1;M1 metabolite of niraparib;尼拉帕尼代谢物

Niraparib metabolite M1 is a metabolite of niraparib, which acts as a poly (ADP-Ribose) polymerase (PARP) inhibitor.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述Niraparib metabolite M1 is a metabolite of niraparib, which acts as a poly (ADP-Ribose) polymerase (PARP) inhibitor.
临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT03329001	Solid Tumor	Phase 1	Recruiting	December 2019	United States, California ... more >> California Cancer Center for Research Excellence cCARE Recruiting Encinitas, California, United States, 92024 Principal Investigator: Alberto Bessudo, MD United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Principal Investigator: R. Donald Harvey, PharmD United States, Tennessee Tennesse Oncology (SCRI) Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Erika Hamilton, MD United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030 Principal Investigator: Sarina Piha-Paul, MD START- South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio, Texas, United States, 78229 Principal Investigator: Amita Patnaik, MD Collapse <<
NCT03551171	Ovarian Cancer	Phase 1	Active, not recruiting	December 30, 2018	China, Beijing ... more >> Beijing Cancer Hospital Beijing, Beijing, China, 100000 China, Guangdong Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510000 China, Heilongjiang Haerbin Medical University Cancer Hospital Harbin, Heilongjiang, China, 150000 China, Hunan Hunan Cancer Hospital Changsha, Hunan, China, 410013 China, Shanghai Fudan University Shanghai Cnacer Center Shanghai, Shanghai, China, 200000 China, Sichuan The West China Second UniversityHospital of Sichuan University Chengdu, Sichuan, China, 610000 Collapse <<

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 3.1116 mL
- 15.5582 mL
- 31.1165 mL
- 5 mM
- 0.6223 mL
- 3.1116 mL
- 6.2233 mL
- 10 mM
- 0.3112 mL
- 1.5558 mL
- 3.1116 mL

技术信息

CAS号	1476777-06-6	储存条件	粉末 Keep in dark place,Sealed in dry,2-8°C 液体 -20°C:3-6 月 -80°C:12月
分子式	C19H19N3O2	运输	蓝冰
分子量	321.37	别名	Niraparib carboxylic acid metabolite M1;M1 metabolite of niraparib;尼拉帕尼代谢物

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT03329001	Solid Tumor	Phase 1	Recruiting	December 2019	United States, California ... more >> California Cancer Center for Research Excellence cCARE Recruiting Encinitas, California, United States, 92024 Principal Investigator: Alberto Bessudo, MD United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Principal Investigator: R. Donald Harvey, PharmD United States, Tennessee Tennesse Oncology (SCRI) Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Erika Hamilton, MD United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030 Principal Investigator: Sarina Piha-Paul, MD START- South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio, Texas, United States, 78229 Principal Investigator: Amita Patnaik, MD Collapse <<
NCT03551171	Ovarian Cancer	Phase 1	Active, not recruiting	December 30, 2018	China, Beijing ... more >> Beijing Cancer Hospital Beijing, Beijing, China, 100000 China, Guangdong Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510000 China, Heilongjiang Haerbin Medical University Cancer Hospital Harbin, Heilongjiang, China, 150000 China, Hunan Hunan Cancer Hospital Changsha, Hunan, China, 410013 China, Shanghai Fudan University Shanghai Cnacer Center Shanghai, Shanghai, China, 200000 China, Sichuan The West China Second UniversityHospital of Sichuan University Chengdu, Sichuan, China, 610000 Collapse <<

Niraparib metabolite M1/尼拉帕尼代谢物 Catalog No. CSN19131

靶点选择性

请登录您的专属账户

确认信息